References
- Kanner L. Autistic disturbances of affective contact. Nervous Children 1943; 2: 217–50.
- Asperger H. Die ‘autistischen Psychopathen’ im Kindesalter. Arch Psych Nerv 1944; 117: 76–136.
- Shattock P, Whiteley P. Biochemical aspects in autism spectrum disorders: updating the opioid- excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 2002; 6: 175–83.
- Knivsberg AM, Reichelt KL, Nødland M. Reports on dietary intervention in autistic disorders.Nutr Neurosci 2001; 4: 25–37.
- Wakefield AJ, Murch SH, Anthony A et al. Ileal-nodular hyperplasia, Non-specific colitis and pervasive developmental disorder in children. Lancet 1998; 351: 637–41.
- Wakefield AJ, Anthony A, Murch SH et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol 2000; 95: 2285–95.
- Alberti A, Pirrone P, Elia M, Waring RH, Romano C. Sulphation deficit in ‘‘low-functioning’’ autistic children: a pilot study. Biol Psychiatr 1999; 46: 420–4.
- Furlano RI, Anthony A, Day R et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001; 138: 366–72.
- Sandler RH, Finegold SM, Bolte ER et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000; 15: 429–35.
- Reichelt KL, Hole K, Hamberger A et al. Biologically active peptide containing fractions in schizophrenia and childhood autism. Adv Bio Psychopharm 1981; 28: 627–43.
- Shattock PEG, Kennedy A, Rowell F, Berney TP. The role of neuropeptides in autism and their relationship with classical neurotransmitters. Brain Dysfunct 1990; 3: 328–45.
- Anderson RJ, Bendell DJ, Garnett I et al. Identification of indolyl-3-acryloylglycine in the urine of people with autism. J Pharm Pharmacol 2002; 54: 295–8.
- Mills MJ, Savery D, Shattock PEG. Rapid analysis of low levels of indolyl-3-acryloylglycine in human urine by high-performance liquid chromatography. J Chromatogr B 1998; 712: 51–8.
- Whiteley P, Rodgers J, Savery D, Shattock P. A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings. Autism 1999; 3: 45–65.
- Hooper M. IAG, a marker molecule for dietary intervention in overlapping syndromes. Nutr Practitioner 2000; 2: 35–6.
- Whiteley P. Developmental, behavioural and somatic factors in pervasive developmental disorders: preliminary analysis. Child: Care, Health Dev, in press.
- Marklova E, Malina L, Hais IM. Urinary excretion of indolyl-3-acryloylglycine in some skin affections. Clin Chim Acta 1975; 64: 273–80.
- Giovanardi Rossi P, Posar A, Parmeggiani A. Epilepsy in adolescents and young adults with autistic disorder. Brain Develop 2000; 22: 102–6.
- Schutz H, Feldmann KF, Faigle JW, Kriemler HP, Winkler T. The metabolism of 14C- oxcarbazepine in man. Xenobiotica 1986; 16: 769–78.
- Wallis P, Williams L, Whiteley P, Shattock P, Lough WJ. Alternative analytical methodology for studying the urine of people with autism. Proceedings of the 13th International Durham Conference, 10–12 April 2002, Durham, UK. Autism Research Unit, UK.